cerivastatin and Vascular-Diseases

cerivastatin has been researched along with Vascular-Diseases* in 2 studies

Other Studies

2 other study(ies) available for cerivastatin and Vascular-Diseases

Article	Year
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al. Diabetes care, 2005, Volume: 28, Issue:5 Topics: Diabetes Mellitus, Type 2; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyridines; Tunica Intima; Tunica Media; Vascular Diseases	2005
Interaction between blood pressure, lipoproteins, angiotensin, and vascular disease. Current hypertension reports, 2002, Volume: 4, Issue:2 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Arteries; Blood Pressure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Risk Factors; Vascular Diseases	2002

Article

Year

Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al.

Diabetes care, 2005, Volume: 28, Issue:5

Topics: Diabetes Mellitus, Type 2; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyridines; Tunica Intima; Tunica Media; Vascular Diseases

2005

Interaction between blood pressure, lipoproteins, angiotensin, and vascular disease.

Current hypertension reports, 2002, Volume: 4, Issue:2

Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Arteries; Blood Pressure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Risk Factors; Vascular Diseases

2002